Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

21.4%

6 terminated/withdrawn out of 28 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

89%

16 of 18 completed trials have results

Key Signals

2 recruiting16 with results

Enrollment Performance

Analytics

N/A
19(90.5%)
Phase 3
1(4.8%)
Phase 2
1(4.8%)
21Total
N/A(19)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT07147218Not ApplicableActive Not Recruiting

Accelerated TMS for MDD

Role: lead

NCT06429748Not ApplicableActive Not Recruiting

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation

Role: lead

NCT01701284Not ApplicableCompleted

Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety

Role: collaborator

NCT06997549Recruiting

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Role: lead

NCT06917339Recruiting

Retrospective Analyses of TrakStar Database

Role: lead

NCT02586688Not ApplicableCompleted

Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents

Role: lead

NCT02441985Not ApplicableCompleted

rTMS Therapy for Primary Orthostatic Tremor

Role: collaborator

NCT01415154Not ApplicableCompleted

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Role: lead

NCT05535062Not ApplicableCompleted

Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature

Role: lead

NCT01842542Not ApplicableTerminated

Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset

Role: lead

NCT06699940Completed

A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents

Role: lead

NCT03363919Not ApplicableCompleted

Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression

Role: collaborator

NCT02542839Not ApplicableCompleted

rTMS and Botulinum Toxin in Primary Cervical Dystonia

Role: collaborator

NCT02131129Not ApplicableCompleted

rTMS in First Episode Psychosis

Role: collaborator

NCT05541302Completed

Retrospective TMS Therapy for Adults With MDD

Role: lead

NCT04217837Withdrawn

Treatment of Major Depressive Disorder in the UK Using TMS Therapy

Role: lead

NCT01718730Completed

Cortical Excitability and Inhibition in MDD

Role: collaborator

NCT02273063Not ApplicableCompleted

rTMS for PTSD Comorbid With Major Depressive Disorder

Role: collaborator

NCT02466230Not ApplicableCompleted

Antidepressant Mechanisms of Transcranial Magnetic Stimulation

Role: collaborator

NCT01900314Not ApplicableCompleted

Imaging Biomarkers for TMS Treatment of Depression

Role: collaborator